个人中心 - 老虎社区

Mglay

IP属地：未知

帖子 · 4帖子 · 4
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- MglayMglay
  ·2021-07-20
  Like
  The SPY Bears Look Strong, But Bulls Have Opportunity
  The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on F
  The SPY Bears Look Strong, But Bulls Have Opportunity
  607 评论
  点赞
  分享
  举报
- MglayMglay
  ·2021-07-20
  Like
  BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum
  BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'
  BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum
  665 评论
  2
  分享
  举报
- MglayMglay
  ·2021-07-20
  Like
  非常抱歉，此主贴已删除
  1,154 评论
  点赞
  分享
  举报
- MglayMglay
  ·2021-07-20
  like
  4 Ways I'm Preparing for the Stock Market Bubble to Burst
  This incredible rally has to end with a spectacular crash sometime ... right? Maybe.
  4 Ways I'm Preparing for the Stock Market Bubble to Burst
  746 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089823128713960","uuid":"4089823128713960","gmtCreate":1626720065560,"gmtModify":1626750300837,"name":"Mglay","pinyin":"mglay","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":171151445,"gmtCreate":1626722997187,"gmtModify":1633924671069,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151445","repostId":"1157946065","repostType":4,"repost":{"id":"1157946065","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626709024,"share":"https://ttm.financial/m/news/1157946065?lang=&edition=full","pubTime":"2021-07-19 23:37","market":"us","language":"en","title":"The SPY Bears Look Strong, But Bulls Have Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1157946065","media":"Benzinga","summary":"The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on F","content":"<p><b>The SPDR S&amp;P 500 ETF</b>&nbsp;(NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.</p>\n<p>On Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"</p>\n<p>Big tech earnings kick off this week with&nbsp;<b>Netflix Inc</b>(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.</p>\n<p>For technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.</p>\n<p><b>The SPY Chart:</b>&nbsp;The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.</p>\n<p>On Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.</p>\n<p>The SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.</p>\n<p><img src=\"https://static.tigerbbs.com/0776e35fc3dd381ce4bc6db6f84308c4\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">There is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.</p>\n<p><b>SPY Price Action:</b>The SPDR S&amp;P 500 was trading down.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The SPY Bears Look Strong, But Bulls Have Opportunity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe SPY Bears Look Strong, But Bulls Have Opportunity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-19 23:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>The SPDR S&amp;P 500 ETF</b>&nbsp;(NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.</p>\n<p>On Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"</p>\n<p>Big tech earnings kick off this week with&nbsp;<b>Netflix Inc</b>(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.</p>\n<p>For technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.</p>\n<p><b>The SPY Chart:</b>&nbsp;The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.</p>\n<p>On Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.</p>\n<p>The SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.</p>\n<p><img src=\"https://static.tigerbbs.com/0776e35fc3dd381ce4bc6db6f84308c4\" tg-width=\"1366\" tg-height=\"768\" width=\"100%\" height=\"auto\">There is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.</p>\n<p><b>SPY Price Action:</b>The SPDR S&amp;P 500 was trading down.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157946065","content_text":"The SPDR S&P 500 ETF (NYSE:SPY) opened down 1.23% Monday morning after declining 0.78% intraday on Friday. The sell-off is being attributed to the increased spread of the COVID-19 Delta variant and inflation fears but the dip could provide opportunities for bullish traders.\nOn Friday, options traders seemed to forecast a gap down on Monday morning and purchased over $9.12 million worth of bearish SPY put contracts. A number of traders purchased puts with a strike price of $430 with an expiry of July 21 which opened \"in-the-money.\"\nBig tech earnings kick off this week with Netflix Inc(NASDAQ:NFLX) reporting Tuesday afternoon and the dip could provide a strong buying opportunity if the streaming company beats expectations. The spread of the Delta variant could also cause the Federal Reserve to pause its talk of tapering, which would be a good sign for the bulls going forward into the third quarter and beyond.\nFor technical traders, regardless of the narrative around the recent pullback, the SPY has key levels to watch.\nThe SPY Chart: The SPY created a bearish double top pattern when it hit a new all-time high of $437.92 on Tuesday and Wednesday of last week. On Friday, the SPY printed a bearish engulfing candlestick pattern indicating lower prices were in the cards for Monday. An engulfing candlestick pattern is recognized by a candle that fully eclipses the previous smaller candlestick and has little or no upper or lower wick.\nOn Monday morning the SPY opened just above a key support zone at the $425 mark, tested the level as support and bounced. The SPY has another support level just below at $422.82 that may provide support if the SPY loses the $425 level.\nThe SPY is trading below both the eight-day and 21-day exponential moving averages (EMAs), which is bearish, but the eight-day EMA is trending above the 21-day EMA, which is bullish. This indicates indecision in the short term. The SPY is trading well above the 200-day simple moving average, which indicates overall sentiment remains bullish for the longer-term outlook.\nThere is support below at $425.77, $422.82, $417.81 and $412. The SPY has psychological support at $400 although the level has yet to be tested by price action.\nSPY Price Action:The SPDR S&P 500 was trading down.","news_type":1,"symbols_score_info":{"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171151505,"gmtCreate":1626722986407,"gmtModify":1633924671191,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151505","repostId":"1160801924","repostType":4,"repost":{"id":"1160801924","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626709874,"share":"https://ttm.financial/m/news/1160801924?lang=&edition=full","pubTime":"2021-07-19 23:51","market":"us","language":"en","title":"BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160801924","media":"Benzinga","summary":"BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'","content":"<p><b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>&nbsp;is&nbsp;buying a cell therapy R&amp;D platform plus a manufacturing site&nbsp;from&nbsp;<b>Gilead Science Inc's</b>GILD 0.91%Kite subsidiary.</p>\n<p>The deal gives BioNTech Kite's R&amp;D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.</p>\n<p>This program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).</p>\n<p>The acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.</p>\n<p>Financial terms were not disclosed.</p>\n<p>Kite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.</p>\n<p><b>Price Action:</b>&nbsp;BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech Snaps Up Solid Tumor TCR Platform, Manufacturing Site From Gilead For Undisclosed Sum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-19 23:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a></b>&nbsp;is&nbsp;buying a cell therapy R&amp;D platform plus a manufacturing site&nbsp;from&nbsp;<b>Gilead Science Inc's</b>GILD 0.91%Kite subsidiary.</p>\n<p>The deal gives BioNTech Kite's R&amp;D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.</p>\n<p>This program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).</p>\n<p>The acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.</p>\n<p>Financial terms were not disclosed.</p>\n<p>Kite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.</p>\n<p><b>Price Action:</b>&nbsp;BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","GILD":"吉利德科学"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160801924","content_text":"BioNTech SE is buying a cell therapy R&D platform plus a manufacturing site from Gilead Science Inc'sGILD 0.91%Kite subsidiary.\nThe deal gives BioNTech Kite's R&D IP for its personalized solid tumor neoantigen T cell receptor (TCR) work and the manufacturing center in Gaithersburg, MD, which supplies the clinical trial product.\nThis program builds and further extends BioNTech's leadership in individualized neoantigen targeting programs such as BNT122 (iNeST) and BNT221 (NEOSTIM).\nThe acquired Gaithersburg facility will provide production capacity to support clinical trials in the U.S. and complement BioNTech's existing cell therapy manufacturing facility in Germany.\nFinancial terms were not disclosed.\nKite's new manufacturing facility in Frederick, MD, for commercial production of CAR T-cell therapy is not part of the purchase agreement.\nPrice Action: BNTX shares are up 0.86% at $233.46 during the market session on the last check Monday.","news_type":1,"symbols_score_info":{"BNTX":0.9,"GILD":0.9}},"isVote":1,"tweetType":1,"viewCount":665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171151222,"gmtCreate":1626722963366,"gmtModify":1633924671313,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171151222","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":1154,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171150991,"gmtCreate":1626721089313,"gmtModify":1633924673795,"author":{"id":"4089823128713960","authorId":"4089823128713960","name":"Mglay","avatar":"https://static.tigerbbs.com/4695d76dba71d1d8067cf3622e9d3192","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089823128713960","authorIdStr":"4089823128713960"},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171150991","repostId":"2152827296","repostType":4,"repost":{"id":"2152827296","kind":"highlight","pubTimestamp":1626663600,"share":"https://ttm.financial/m/news/2152827296?lang=&edition=full","pubTime":"2021-07-19 11:00","market":"us","language":"en","title":"4 Ways I'm Preparing for the Stock Market Bubble to Burst","url":"https://stock-news.laohu8.com/highlight/detail?id=2152827296","media":"Motley Fool","summary":"This incredible rally has to end with a spectacular crash sometime ... right? Maybe.","content":"<p>Does the <b>S&amp;P 500</b>'s nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.</p>\n<p>If you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.</p>\n<h3>1. I'm scaling out of frothier, more speculative names</h3>\n<p>I confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, <b>AMC Entertainment</b>.</p>\n<p>Most investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.</p>\n<h3>2. I'm prioritizing cash over equities</h3>\n<p>At first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.</p>\n<p>To be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.</p>\n<p>It's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant <b>Procter &amp; Gamble</b> fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name <b>The Southern Company</b> fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.</p>\n<p>The point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.</p>\n<h3>3. I'm adding (a little) gold</h3>\n<p>While most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.</p>\n<p>I'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.</p>\n<p>Commodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the <b>SPDR Gold Trust</b>.</p>\n<h3>4. Mostly, I'm doing nothing</h3>\n<p>Finally, and perhaps most importantly, I'm doing nothing about a possible market correction.</p>\n<p>You read that right.</p>\n<p>There are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.</p>\n<p>The other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's<i> not</i> going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Ways I'm Preparing for the Stock Market Bubble to Burst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Ways I'm Preparing for the Stock Market Bubble to Burst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 11:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/07/18/4-ways-im-preparing-for-stock-market-bubble-burst/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152827296","content_text":"Does the S&P 500's nearly 100% gain from last March's low have you a little worried about a pullback? You're not alone. Even though much of this move was a recovery from the steep sell-off sparked by the onset of the COVID-19 pandemic, much of it has also just been plain old bullishness ... perhaps a little too much. Stocks are still chugging along, but at times, it feels like the only thing keeping the rally going is its momentum. That's not good.\nIf you're concerned the market bubble is going to pop soon, feel free to rip a few pages out of my personal playbook. Notice that none of them are particularly complicated moves.\n1. I'm scaling out of frothier, more speculative names\nI confess, some of the names I've picked up over the course of the past year or so aren't exactly the sorts of stocks I fully intended to hold for the long haul. They were closer to being bets than investments, which can be fun and rewarding but not exactly safe when the market starts to unravel. As the old adage goes, the higher they fly, the farther they fall. That's especially true when a company can't even come close to justifying its stock price with actual fundamentals. Yes, I'm looking at you, AMC Entertainment.\nMost investors innately know this is the smart-money move to make when the broad market is closer to a major high than a major low. Some investors, however, just need to hear someone else say it. I just did.\n2. I'm prioritizing cash over equities\nAt first glance, this seems a lot like the aforementioned move -- backing off on my exposure to riskier equities. After all, if I'm selling anything, those proceeds are inherently turned into cash anyway.\nTo be clear, however, I'm not merely swapping out my more speculative, vulnerable names for more reliable blue chips. I'm reducing my overall exposure to the market by converting a sizable stake of my holdings to cash.\nIt's not always a fully understood (or even believed) facet of investing, but \"safe\" stocks like consumer goods names and utilities companies aren't actually protection from a correction. Shares of consumer packaged goods giant Procter & Gamble fell nearly 24% between last year's February high and March low when the coronavirus began to spread across the world, including within the U.S. Utility name The Southern Company fell 39% during this timeframe. Both recovered -- and then some -- but neither actually offered any true defense from sweeping weakness.\nThe point is, during market corrections, there's really no place to hide. You'll just have to let the long-term holdings you're committed to take their lumps on faith they'll bounce back. If you don't have that faith with any particular stock, just replace it with cash until the dust settles.\n3. I'm adding (a little) gold\nWhile most stocks are going to be dragged lower by a market-wide correction, not every sort of holding is a stock. There are also bonds and commodities, which still trade independently of equities. That doesn't preclude them from pulling back if and when the stock market does. But if they do peel back, they're doing so independently of the broad market.\nI'm not bothering with bonds right now. Interest rates are pointlessly low, and with inflation seemingly on the verge of racing out of control, bonds are little more than a coin toss at this time anyway.\nCommodities, however, are a different story. If anything, they've become bigger movers against a rising inflation backdrop and a Federal Reserve that's being increasingly pressured to respond. Should stocks tank, commodities -- already pumped and primed -- may see a swell of demand that drives prices higher. The easiest way to plug into this dynamic is with a simple pick like the SPDR Gold Trust.\n4. Mostly, I'm doing nothing\nFinally, and perhaps most importantly, I'm doing nothing about a possible market correction.\nYou read that right.\nThere are two schools of thought behind the decision to do nothing rather than trying to evade the impact of a correction. The first of these is the simple fact that most of my holdings really are long-haul positions I had (and have) every intention of hanging onto through bear markets. One of the greatest upsides of a legitimate buy-and-hold approach is that you don't even have to worry about temporary headwinds.\nThe other idea at work here is the fact that guessing the market's next near-term reversal is just darn difficult to do ... so much so that most people don't do it very well. Indeed, the effort to time the stock market's peaks and valleys often does more harm than good, by virtue of getting you out too soon or too late, or getting you back in too soon or too late. The market's going to do what the market's going to do in its own time, and it's not going to telegraph what's around the corner to anyone. The best way to win that game is by not playing it at all.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}